Kane Biotech Inc. (TSXV:KNE)

Canada · Delayed Price · Currency is CAD

0.0350

0.00 (0.00%)

May 20, 2026, 12:16 PM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Animal Health	410.00K	2.49M	2.78M	-	-
Animal Health Growth	-83.50%	-10.56%	-	-	-
Human Health	17.87K	675.37K	39.09K	-	-
Human Health Growth	-97.35%	1627.55%	-	-	-
ALL Other Segments	-	-	-	156.73K	-
Total	427.87K	3.16M	2.82M	156.73K	-
Total Growth	-86.46%	12.17%	1697.82%	-	-

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Canada	1.37M	35.23K	931.95K
Canada Growth	3791.03%	-96.22%	39.46%
International	1.45M	121.50K	675.82K
International Growth	1090.85%	-82.02%	0.37%
Total	2.82M	156.73K	1.61M
Total Growth	1697.82%	-90.25%	19.84%

Source: S&P Global Market Intelligence.